Atlas Trials

An Early Stage Study to Evaluate Oba01 for Injection in Patients With DR5 Positive LA/mNSCLC

Clinical trial NCT06083870 · UNKNOWN

Trial details

NCT number
NCT06083870
Sponsor
Lu Shun
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer Metastatic
Start date
2023-12-13
Primary completion
2025-07-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.